| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Mark A Zorko is Director at NUS, with reported holdings spanning 2 companies. Mark A Zorko's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $298K at current prices.
Mark A Zorko's largest disclosed position is in NUS as Director, worth about $298K.
Mark A Zorko has 7 Form 4 filings on record from April 2016 to June 2026, across 2 companies: Director at Nu Skin Enterprises (NUS), 2024–2026; Director at Perma-Pipe International (PPIH), 2016–2019.
The 13 reported transactions were 5 open-market sales, 4 option exercises, 3 stock awards and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $175K.
The largest open-market sale was 12,500 shares of PPIH at an average $8.55 on January 11, 2019, about $107K.